Setrusumab, CAS 1847394-95-9

Product Description: Setrusumab (BPS 804) is a fully human monoclonal antibody targets sclerostin. Setrusumab efftively improves bone strength. Setrusumab can be used for the resesrch of Osteogenesis Imperfecta (OI) and cancer[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Hesse E, et al. Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness. JCI Insight. 2019 Apr 9;5(9):e125543.

CAS Number: 1847394-95-9

Molecular Weight: N/A

Compound Purity: 98.03

Research Area: Cancer; Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Others

• SKU: MEXHY-P99398-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99398-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated